N^N^C-Cyclometalated rhodium(III) complexes with isomeric pyrimidine-based ligands: unveiling the impact of isomerism on structural motifs, luminescence and cytotoxicity

The impact of isomerism of pyrimidine-based ligands and their rhodium(III) complexes with regard to their structures and properties was investigated. Two isomeric ligands, 4-(3,5-dimethyl-1H-pyrazol-1-yl)-2,5-diphenylpyrimidine (HL2,5) and 4-(3,5-dimethyl-1H-pyrazol-1-yl)-2,6-diphenylpyrimidine (HL2,6), were synthesized. The ligands differ by the degree of steric bulk: the molecular structure of HL2,5 is more distorted due to presence of pyrazolyl and phenyl groups in the neighbouring positions 4 and 5 of the pyrimidine ring. The complexation of HL2,5 and HL2,6 with RhCl3 leads to the sp2 C-H bond activation, resulting in the isolation of two complexes, [RhL2,5(Solv)Cl2]·nEtOH and [RhL2,6(Solv)Cl2]·nEtOH (Solv = H2O, EtOH), with the deprotonated forms of the pyrazolylpyrimidine molecules which coordinate the Rh3+ ion as N^N^C-tridentate ligands. According to DFT modelling, the mechanism of the deprotonation involves (i) the C-H bond breaking in the 2-phenyl group followed by the coordination of the C atom to the Rh atom, (ii) the protonation of coordinated chlorido ligand, (iii) the ejection of the HCl molecule and (iv) the coordination of the H2O molecule. The ligand isomerism has an impact on emission properties and cytotoxicity of the complexes. Although the excited states of the complexes effectively deactivate through S0/T1 and S0/S1 crossings associated with the cleavage of the weak H2O ligands upon excitation, the [RhL2,5(Solv)Cl2]·nEtOH complex appeared to be emissive in the solid state, while [RhL2,6(Solv)Cl2]·nEtOH is non-emissive at all. The complexes show significant cytotoxic activity against cancerous HepG2 and Hep2 cell lines, with the [RhL2,6(Solv)Cl2]·nEtOH complex being more active than its isomer [RhL2,5(Solv)Cl2]·nEtOH. On the other hand, noticeable cytotoxicity of the latter against HepG2 is supplemented by its non-toxicity against non-cancerous MRC-5 cells.

Synthesis and Study of Photothermal Properties of a Mixed-Valence Nanocluster CuI/CuII with Strong near-Infrared Optical Absorption Supported by 4-tert-Butylcalix[4]arene Ligand

The first mixed-valence nanocluster Cu^I/Cu^II with the highest percentage of Cu^II ions was synthesized by using 4-tert-butylcalix[4]arene (Calix4), with the formula DMF₂⊂[(CO₃)^2-@Cu^II₆Cu^I₃(Calix4)₃Cl₂(DMF)₅(H₃O)]•DMF (1), as a photothermal nanocluster. Its structure was characterized using single-crystal X-ray diffraction, Fourier-transform infrared spectroscopy, and powder X-ray diffraction. In addition, the charge state and chemical composition of the nanocluster were determined using electrospray ionization spectrometry and X-ray photoelectron spectroscopy (XPS) spectrum. The results of the XPS and X-ray crystallography revealed that there are two independent Cu^II and Cu^I centers in nanocluster 1 with the relative abundances of 66.6 and 33.3% for Cu^II and Cu^I, respectively. The nanocluster contains three four-coordinated Cu^I ions with a square-planar geometry and six five-coordinated Cu^II ions with a square pyramid geometry. The nanocluster shows strong near-infrared optical absorption in the solid state and excellent photothermal conversion ability (the equilibrium temperature ∼78.2 °C) with the light absorption centers in 286-917 nm over previous reported pentanucleus Cu^I₄Cu^II clusters and Cu^II compounds.

Versatile coordination behaviour of the chloro-tetrazine-picolylamine ligand: mixed-valence binuclear Cu(i)/Cu(ii) complexes

The 3-Cl-6-amino-(2'-picolyl)-1,2,4,5-tetrazine ligand HL¹ has been synthesized and structurally characterized. Its versatile coordination behavior has been evidenced through reactions with Cu(Hfac)₂ and Cu(triflate)₂ precursors, which provided mixed-valence bimetallic Cu^1.5Cu^1.5 complexes [Cu₂(μ-Cl)(L¹)₂] 2 and [Cu₂(μ-triflate)(L¹)₂] 5. Changing the Cu(ii) precursor and the solvent leads to the formation of mononuclear octahedral Cu(ii) complexes [CuCl₂(HL¹)₂]·2CH₃CN 3 and [Cu(Hfac)₂(HL¹)] 4, in which only the amino-pyridine unit is involved in the coordination of the metal center. In contrast, in complexes 2 and 5, the ligands are deprotonated and bridge the metal centers as pyridine-amido-tetrazine fragments, while a bridging chloride or triflate ligand completes the coordination sphere of the metal ions. The Cu-Cu distances of 2.4313(4) Å in 2 and 2.5198(10) Å in 5 lie among the shorter values within mixed-valence bimetallic Cu complexes. Mixed-valence character is strongly supported by DFT calculations, showing the equal repartition of the unpaired electron between the two metal centers.

Trinuclear copper(ii) bromide complex [C3H5N3Br]2n[Cu3Br8]n. Structure, magnetic properties and DFT calculations

Halidocuprates(ii) show unusual magnetic properties and a high degree of structural flexibility.

Crystal structure of 4-(pyrazin-2-yl)morpholine

The mol-ecular structure of the title compound, C8H11N3O, is nearly planar despite the chair conformation of the morpholine moiety. In the crystal, the mol-ecules form sheets parallel to the b axis, which are supported by non-classical hydrogen-bonding inter-actions between C-H functionalities and the O atom of morpholine and the 4-N atom of pyrazine, respectively. The title compound crystallizes in the monoclinic space group P21/c with four mol-ecules in the unit cell.